First Time Loading...
T

Teva Pharmaceutical Industries Ltd
TASE:TEVA

Watchlist Manager
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Watchlist
Price: 4 933 ILS 0.98% Market Closed
Updated: Apr 28, 2024
TEVA
/
Income Statement
/
Revenue

Teva Pharmaceutical Industries Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Teva Pharmaceutical Industries Ltd
Revenue Peer Comparison

Comparables:
TARO
I
INCR
MDWD
R
REKA
C
CSURE

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
T
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Revenue
$15.8B
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
-2%
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Revenue
$610.8m
CAGR 3-Years
2%
CAGR 5-Years
-2%
CAGR 10-Years
-2%
I
InterCure Ltd
TASE:INCR
Revenue
₪414.8m
CAGR 3-Years
164%
CAGR 5-Years
N/A
CAGR 10-Years
48%
Mediwound Ltd
NASDAQ:MDWD
Revenue
$18.7m
CAGR 3-Years
-5%
CAGR 5-Years
41%
CAGR 10-Years
N/A
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Revenue
₪315.3m
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
1%
C
Cannassure Therapeutics Ltd
TASE:CSURE
Revenue
₪33.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

Teva Pharmaceutical Industries Ltd
Revenue Breakdown

Breakdown by Geography
Teva Pharmaceutical Industries Ltd

Not Available

Breakdown by Segments
Teva Pharmaceutical Industries Ltd

Total Revenue: 15.8B USD
100%
Product: 12.8B USD
80.6%
North America Segment: 7.5B USD
47%
Europe Segment: 4.5B USD
28.6%
International Markets: 1.9B USD
12%
Generics Medicians: 1.6B USD
10%
Distribution Service: 1.5B USD
9.6%
Anda: 1.5B USD
9.3%
Other Activities: 1B USD
6.6%
Austedo: 963m USD
6.1%
Product And Service, Other: 428m USD
2.7%
Bendeka And Treanda: 316m USD
2%
Respiratory Product: 273m USD
1.7%
Other Products: 246m USD
1.6%
License: 212m USD
1.3%
Copaxone: 36m USD
0.2%
Ajovy: 35m USD
0.2%
Show More
Show Less

See Also

What is Teva Pharmaceutical Industries Ltd's Revenue?
Revenue
15.8B USD

Based on the financial report for Dec 31, 2023, Teva Pharmaceutical Industries Ltd's Revenue amounts to 15.8B USD.

What is Teva Pharmaceutical Industries Ltd's Revenue growth rate?
Revenue CAGR 10Y
-2%

Over the last year, the Revenue growth was 6%. The average annual Revenue growth rates for Teva Pharmaceutical Industries Ltd have been -2% over the past three years , -3% over the past five years , and -2% over the past ten years .

ALPHA SPREAD
Join more than 132,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.